Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01686685 : Correlation of CXCR4 Expression in Premature Infants With a Diagnosis of Autism at 24 Months
PhaseN/A
AgesMin: N/A Max: 1 Day
Eligibility
Inclusion Criteria:

- Parents gave informed consent approved by the Institutional Review Board

- Gestational week 28-34 as determined by an ultrasound during the first trimester

- Singleton or twin pregnancy

Exclusion Criteria:

- Major anatomical abnormalities as detected on prenatal US

- Genetic syndrome as detected by prenatal US, MRI or chorioamniocentesis

- Obvious anatomical abnormalities or dysmorphic features detected on physical
examination immediately following birth

- Triplet pregnancy

- Mother known or suspected to consume alcohol or illegal drugs during pregnancy

- Mother took medications during pregnancy that are known to have adverse affects on
development (e.g. anti-epileptics)

- Family history of genetic syndrome related to developmental delays, that was not
ruled out during current pregnancy (e.g. sibling with Tuberous Sclerosis or fragile
X)
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01686685      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740